NASDAQ
Collegium Pharmaceutical, Inc. (COLL) has a current ratio of 1.57x as of Monday, May 25, 2026. This represents a 49.02% increase compared to its 12-month average of 1.05x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.